Compare Corsair Gaming Inc (CRSR) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corsair Gaming Inc vs Tenet Healthcare Corporation — how do they compare? Corsair Gaming Inc trades at $13.22 (market cap $1.42B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 14.8× Corsair Gaming Inc's market cap, and Tenet Healthcare Corporation is more actively traded (428,008 versus 1,160,938). Which is the better fit depends on your goals — on Pluang, investors hold Corsair Gaming Inc for 25 Days and Tenet Healthcare Corporation for 15 Days on average.
| CRSR | THC | |
|---|---|---|
Market Cap | $1.42B | $20.98B |
Volume | 1,160,938 | 428,008 |
Sector | Technology | Health |
52-Week High | $14.35 | $280.77 |
52-Week Low | $4.58 | $161.37 |
Typical Hold Time | 25 Days | 15 Days |
Enterprise Value | $1.41B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Corsair Gaming (CRSR) trades at $13.59, down slightly by 0.37% on the day. The stock exhibits a bullish technical signal with recent earnings beats in Q4 2025, Q1 2026, and Q2 2026. Revenue for 2025 was $1.47 billion, though net income was negative $16.16 million. The company launched new products like the VOXARA microphone and acquired Trak Racer assets, signaling growth initiatives. Analyst consensus is a 'Hold' with a price target of $12.40, below the current price, indicating caution despite positive momentum.
The outlook for CRSR is mixed; strong earnings performance and product innovation offer upside, but valuation concerns and negative net income pose risks. Investors should weigh the bullish technical trends and recent institutional interest against the high P/E ratio of 42.23 and analyst price targets suggesting limited near-term gains. Key risks include competitive pressures and execution challenges in the gaming hardware market.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Corsair Gaming Inc
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
